Regarding the stock acquisition rights (17th, with exercise price adjustment clause) for the target month, July exercises were 0 shares, and 80,800 shares remained unexercised. The number of outstanding issued shares at the end of the previous month was 9,030,000 shares, with 289,868 treasury shares.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4840","jir_company_name":"TriEyes Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-08-03","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/4840-20260803-01.pdf","jir_short_summary":"Regarding the stock acquisition rights (17th, with exercise price adjustment clause) for the target month, July exercises were 0 shares, and 80,800 shares remained unexercised. The number of outstanding issued shares at the end of the previous month was 9,030,000 shares, with 289,868 treasury shares.","jir_summary":"### Disclosure status\nThis report notifies the monthly exercise status of the 17th stock acquisition rights (with exercise price adjustment clause) in July 2026, with 0 exercises and 0 shares issued during the target month. Total issued units were 18,100, and the monthly exercise ratio was 0.00%, at a low level. Unexercised stock acquisition rights at the end of the previous month and the end of the target month remain 8,800 units.\n\n### Impact on shareholders and outlook\nThis report discloses actual exercise results only and does not indicate any direct changes to dilution impact or capital policy. Going forward, exercise status of stock acquisition rights is expected to continue being disclosed, and impact on shareholders is anticipated to be limited.","jir_financial_highlights":"Outstanding issued shares: 9,030,000 shares (\u672a\u77e5)\nTreasury shares: 289,868 shares (\u672a\u77e5)\nUnexercised stock acquisition rights (end of previous month): 8,800 shares (\u672a\u77e5)\nUnexercised stock acquisition rights (end of target month): 8,800 shares (\u672a\u77e5)","jir_category":"","jir_hashtags":"#TriEyes, #IR, #JapaneseStocks","jir_key_figures":"Outstanding issued shares: 9,030,000 shares\nTreasury shares: 289,868 shares\nUnexercised stock acquisition rights: 8,800 units\nTotal stock acquisition rights: 18,100 units","jir_meta_title":"TriEyes: Monthly Exercise Status of Stock Acquisition Rights Published | July 2026","jir_meta_description":"TriEyes, Inc. announces July exercise status of the 17th stock acquisition rights. Issued shares zero, unexercised 8,800, total 18,100. Limited impact on shareholders expected.","jir_og_title":"TriEyes: Monthly Exercise Status of Stock Acquisition Rights Published | July 2026","jir_og_description":"Disclosure of the July exercise status of the 17th stock acquisition rights. 0 issued shares, 8,800 unexercised, total 18,100. Look forward to future developments.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":60349,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"disclosure_update","footnotes":""},"sector":[],"importance":[],"class_list":["post-93472","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n